| 1 |
32206108 | The failure of DAC to induce OCT2 expression and its remission by hemoglobin-based nanocarriers under hypoxia in renal cell carcinoma. | 2020 |
1 |
| 2 |
30501707 | [Clinical Efficacy and Prognostic Factors of Decitabine for Treatment of Myelodysplastic Syndrome]. | 2018 Dec |
1 |
| 3 |
29174536 | Monophosphorylation by deoxycytidine kinase affects apparent cellular uptake of decitabine in HCT116 colon cancer cells. | 2017 Dec |
2 |
| 4 |
26944860 | High expression of the human equilibrative nucleoside transporter 1 gene predicts a good response to decitabine in patients with myelodysplastic syndrome. | 2016 Mar 5 |
7 |
| 5 |
25533931 | The hENT1 and DCK genes underlie the decitabine response in patients with myelodysplastic syndrome. | 2015 Feb |
4 |
| 6 |
26031529 | [Functional study of hENT1 on SKM-1 cell resistance to decitabine]. | 2015 May |
5 |
| 7 |
22356238 | Role of human nucleoside transporters in the uptake and cytotoxicity of azacitidine and decitabine. | 2012 |
1 |
| 8 |
16333246 | The human equilibrative nucleoside transporter 1 mediates in vitro cytarabine sensitivity in childhood acute myeloid leukaemia. | 2005 Dec 12 |
1 |